Key Documents

View All Documentation

A79809

5-Aminosalicylic acid

Name: 5-Aminosalicylic acid
Brand: ALDRICH

95%

Synonym(s):

5-AS, 5-Amino-2-hydroxybenzoic acid, Mesalamine

Select a Size

Change View

About This Item

Linear Formula:

H₂NC₆H₃-2-(OH)CO₂H

CAS Number:

89-57-6

Molecular Weight:

153.14

UNSPSC Code:

12352106

NACRES:

NA.22

PubChem Substance ID:

24891301

EC Number:

201-919-1

Beilstein/REAXYS Number:

2090421

MDL number:

MFCD00007877

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

assay

95%

form

powder with small lumps

reaction suitability

reaction type: solution phase peptide synthesis

mp

275-280 °C (dec.) (lit.)

application(s)

detection
peptide synthesis

SMILES string

Nc1ccc(O)c(c1)C(O)=O

InChI

1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)

InChI key

KBOPZPXVLCULAV-UHFFFAOYSA-N

Gene Information

human ... ALOX5(240), PPARG(5468), PTGS1(5742), PTGS2(5743)

Description

Application

5-Aminosalicylic acid is a peroxidase substrate suitable for use in ELISA procedures. This substrate produces a soluble end product that is brown in color and can be read spectrophotometrically at 450 nm. The reaction may be stopped with 3 N NaOH and read at 550 nm.

Still not finding the right product?

Explore all of our products under 5-Aminosalicylic acid

pictograms

GHS07

signalword

Warning

hcodes

H315,H317,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Storage Class

13 - Non Combustible Solids

wgk

WGK 2

flash_point_f

No data available

flash_point_c

No data available

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.

W Kruis et al.

Alimentary pharmacology & therapeutics, 37(7), 680-690 (2013-02-19)

Robust evidence regarding medical intervention for symptomatic uncomplicated colonic diverticular disease (DD) is sparse. To investigate mesalazine (Salofalk granules) in this setting. In a double-blind, placebo-controlled, multicentre, 6-week trial, patients were randomised to mesalazine 1000 mg three times daily or placebo.

Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.

Urpo Nieminen et al.

International journal of cancer, 134(1), 189-196 (2013-06-26)

Patients with long-standing inflammatory bowel disease (IBD) have an increased risk for colorectal carcinoma (CRC). Earlier studies suggest that the severity of inflammation is an independent risk factor for CRC in ulcerative colitis (UC). We investigated the role of histological

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission.

Mirjana Rajilić-Stojanović et al.

Inflammatory bowel diseases, 19(3), 481-488 (2013-02-07)

Presence of intestinal microbes is a prerequisite for the development of ulcerative colitis (UC), although deviation of the normal intestinal microbiota composition, dysbiosis, is presumably implicated in the etiology of UC. The fecal microbiota of 30 UC samples obtained from

View All Related Papers

Global Trade Item Number

SKU	GTIN
A79809-100G	04061833390870
A79809-5G	04061833390887